Latest Synthetic biology Stories
The Danish-based synthetic biology company Biosyntia ApS has completed a DKK 12.5 M financing round with Novo Seeds as lead investor. (PRWEB) May 21, 2015
Poll Respondents Uncertain on Potential, But Support Ban on Human-based Research WASHINGTON, May 21, 2015 /PRNewswire-USNewswire/ -- A new poll finds Americans ambivalent
-- Platform Delivers High-Quality Genes Using 10,000-well Silicon-Based Proprietary Platform -- SAN FRANCISCO, April 22, 2015 /PRNewswire/ -- Twist Bioscience, a company focused
Results have important implications in developing algae-based products such as biofuels and chemicals LA JOLLA, Calif., April 21, 2015 /PRNewswire-USNewswire/ -- Scientists from the
BioXp(TM) System Provides Scientists with Ability to Create High Quality, Synthetic DNA Fragments; Key to Constructing Synthetic Genes, Gene Pathways and Whole Genomes LA JOLLA, Calif.,
LONDON, March 24, 2015 /PRNewswire/ -- The global market for agricultural biotechnology reached $26.4 billion in 2013 and $27.8 billion in 2014.
SAN FRANCISCO, Feb. 3, 2015 /PRNewswire/ -- Twist Bioscience today named Patrick J. Finn, Ph.D., as vice president of sales and marketing. Dr.
Good GMOs? Scientists developing a way to produce safer and more effective GMO using bacteria that cannot spread in the wild.
Rising concerns over fuel consumption and increasing demand for protein therapeutics are likely to create opportunities for Synthetic Biology Market.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).